Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Hydrocortisone Does Not Prevent Lung Complication in Extremely Preterm Infants

March 23, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research supported in part by NCATS. The study of a potential treatment for the condition, known as bronchopulmonary dysplasia, appears in The New England Journal of Medicine.

Ketogenic Diet Leads to Cognitive Improvement in Patients with Mild Alzheimer’s Disease

March 22, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

CTSA Program-supported researchers tested the hypothesis that ketones could provide a new source of energy for the brain in people with Alzheimer’s disease (AD). The study found improved brain function in people with mild AD after a three-month ketogenic diet.

NCATS-Supported Research Reduces Time to Diagnosis for Seriously Ill Children with Genetic Diseases

March 11, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

NCATS-supported researchers have developed an automated approach to diagnosis of genetic diseases in seriously ill children to allow faster diagnosis and initiation of treatment, and, ultimately, better outcomes. The study appeared in the April 24, 2019, issue of Science Translational Medicine.

NCATS, Duke Scientists Show Compound’s Novel Effects on Key Brain Chemical in Drug Addiction

March 3, 2022 - NCATS News

  • Chemistry Technology
  • Compound Management

Scientists at NCATS and Duke University discovered a compound that can control the brain’s levels of dopamine — a chemical that can fuel addictive behavior — offering a potential approach to help treat addiction, as well as Parkinson’s and age-related brain diseases.

An Itch to Scratch: NCATS, NIDCR Scientists Identify Potential New Approach to Chronic Problem

February 22, 2022 - NCATS News

  • Preclinical Chemical Biology Laboratory

People with constantly itchy skin, take heart. NCATS and National Institute of Dental and Craniofacial Research scientists report that blocking a receptor on the surface of spinal cord neurons may help relieve the chronic need to scratch. The study appeared online on July 10 in Science Translational Medicine.

Robots Could Spur Use of Stem Cells in the Laboratory and Clinic

February 14, 2022 - NCATS News

  • Automation
  • Our Impact on Research Operations
  • Stem Cell Translation Laboratory (SCTL)

NCATS scientists used robots to automate the culturing of stem cells, thus speeding up the process and bringing stem cells one step closer to clinical use.

Last updated on July 9, 2026